Delhi, India

Shweta Saxena


Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 34(Granted Patents)


Company Filing History:


Years Active: 2007-2008

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Shweta Saxena: Innovator in Genetic Research

Introduction

Shweta Saxena is a prominent inventor based in Delhi, India. She has made significant contributions to the field of genetic research, particularly in the detection of gene variants associated with various diseases. With a total of 2 patents, her work is paving the way for advancements in molecular diagnostics.

Latest Patents

Shweta's latest patents include a method for detecting SP-A2 gene variants, which provides a means for predicting an individual's susceptibility to pulmonary tuberculosis. This method involves amplifying genomic DNA from both pulmonary tuberculosis patients and normal control individuals using oligonucleotide primers. The amplified PCR product is sequenced, and the sequence variation is identified computationally by comparing it with the existing sequence of the human SP-A2 gene.

Another notable patent is a method for detecting SP-A2 gene variants that is useful for predicting predisposition to aspergillosis. This invention utilizes allele-specific primers and probes suitable for detecting allelic variants of the human SP-A2 gene, which can be applied in molecular diagnosis and genetic analysis within populations.

Career Highlights

Shweta Saxena is currently affiliated with the Council of Scientific & Industrial Research, where she continues her research and innovation in genetics. Her work has garnered attention for its potential impact on public health and disease prevention.

Collaborations

Shweta collaborates with esteemed colleagues, including Puranam Usha Sarma and Taruna Madan, who contribute to her research endeavors.

Conclusion

Shweta Saxena's innovative work in genetic research exemplifies the importance of scientific advancements in understanding and combating diseases. Her contributions are vital for the future of molecular diagnostics and public health.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…